William Blair Has Pessimistic Outlook of Avantor Q3 Earnings

Key Points

• William Blair has revised its Q3 2025 earnings estimates for Avantor, Inc., lowering the expected earnings per share from $0.27 to $0.22.
• Several analysts have decreased their price targets for Avantor, with Barclays and Royal Bank of Canada lowering targets to $13.00 and $17.00, respectively.
• The company's recent earnings report showed a miss with $0.24 earnings per share, which fell short of the $0.25 consensus estimate.

Avantor, Inc. (NYSE:AVTR - Free Report) - Stock analysts at William Blair dropped their Q3 2025 earnings estimates for shares of Avantor in a research note issued on Monday, August 4th. William Blair analyst M. Larew now anticipates that the company will earn $0.22 per share for the quarter, down from their prior forecast of $0.27. The consensus estimate for Avantor's current full-year earnings is $1.06 per share. William Blair also issued estimates for Avantor's Q4 2025 earnings at $0.25 EPS, FY2025 earnings at $0.94 EPS, Q1 2026 earnings at $0.24 EPS, Q2 2026 earnings at $0.27 EPS, Q3 2026 earnings at $0.26 EPS, Q4 2026 earnings at $0.30 EPS and FY2026 earnings at $1.07 EPS.

AVTR has been the topic of a number of other reports. Barclays dropped their price objective on shares of Avantor from $15.00 to $13.00 and set an "overweight" rating on the stock in a research note on Monday. Royal Bank Of Canada lowered their target price on shares of Avantor from $20.00 to $17.00 and set an "outperform" rating for the company in a research note on Monday. Jefferies Financial Group restated a "hold" rating on shares of Avantor in a research note on Friday. JPMorgan Chase & Co. lowered their target price on shares of Avantor from $17.00 to $14.00 and set an "overweight" rating for the company in a research note on Monday. Finally, Evercore ISI lowered their target price on shares of Avantor from $18.00 to $16.00 and set an "outperform" rating for the company in a research note on Monday. Eight equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $15.50.

Avantor Price Performance

NYSE AVTR opened at $11.36 on Tuesday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.67 and a current ratio of 0.98. The firm's 50 day moving average price is $13.35 and its 200-day moving average price is $15.32. Avantor has a 52-week low of $10.82 and a 52-week high of $27.83. The company has a market cap of $7.74 billion, a PE ratio of 11.47, a P/E/G ratio of 1.21 and a beta of 0.96.

Avantor (NYSE:AVTR - Get Free Report) last issued its earnings results on Friday, August 1st. The company reported $0.24 EPS for the quarter, missing analysts' consensus estimates of $0.25 by ($0.01). The company had revenue of $1.68 billion for the quarter, compared to analysts' expectations of $1.67 billion. Avantor had a return on equity of 11.39% and a net margin of 10.31%. The business's revenue was down 1.1% compared to the same quarter last year. During the same period last year, the business posted $0.25 earnings per share.

Institutional Trading of Avantor

A number of large investors have recently bought and sold shares of the business. Rise Advisors LLC purchased a new position in shares of Avantor in the 1st quarter valued at about $25,000. Northwestern Mutual Wealth Management Co. increased its holdings in shares of Avantor by 288.4% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 1,701 shares of the company's stock valued at $28,000 after purchasing an additional 1,263 shares in the last quarter. Wealthquest Corp purchased a new position in shares of Avantor in the 1st quarter valued at about $34,000. FNY Investment Advisers LLC purchased a new position in shares of Avantor in the 2nd quarter valued at about $36,000. Finally, Spire Wealth Management purchased a new position in shares of Avantor in the 2nd quarter valued at about $47,000. Institutional investors and hedge funds own 95.08% of the company's stock.

Insider Activity

In related news, Director Gregory L. Summe bought 30,000 shares of the stock in a transaction dated Friday, May 23rd. The stock was acquired at an average price of $12.50 per share, for a total transaction of $375,000.00. Following the acquisition, the director owned 100,000 shares in the company, valued at approximately $1,250,000. This represents a 42.86% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In the last ninety days, insiders have acquired 75,000 shares of company stock valued at $928,000. Corporate insiders own 1.20% of the company's stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.